Source: Eur Respir J 2014; 43: 685-688
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hassoun Paul M.. Inflammation in pulmonary arterial hypertension: is it time to quell the fire?. Eur Respir J 2014; 43: 685-688

Member's Comments

No comment yet.

Related content which might interest you: Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension Source: Eur Respir Rev, 30 (162) 210161; 10.1183/16000617.0161-2021 Year: 2021 Pulmonary arterial hypertension: an autoimmune disease? Source: Eur Respir J 2005; 26: 986-988 Year: 2005 Pulmonary arterial hypertension and the state of limbo Source: Eur Respir Rev 2010 19: 264-265 Year: 2010 ?-blockers in pulmonary arterial hypertension: generation might matter Source: Eur Respir J 2016; 47: 682-684 Year: 2016 Is there an obesity paradox in pulmonary arterial hypertension? Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Inflammation in chronic thromboembolic pulmonary hypertension: accomplice or bystander in altered angiogenesis? Source: Eur Respir J 2015; 46: 303-306 Year: 2015 Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed Source: Eur Respir J 2010; 36: 986-990 Year: 2010 Pulmonary arterial hypertension among elderly patients: an emerging problem? Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015 Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 “Rehab for all!” Is it too early in pulmonary arterial hypertension? Source: Eur Respir J, 54 (5) 1901558; 10.1183/13993003.01558-2019 Year: 2019 Pulmonary arterial hypertension and the Enigma code of smouldering inflammation Source: Eur Respir J 2016; 48: 305-307 Year: 2016 How does inflammation contribute to pulmonary hypertension? Source: Eur Respir J, 51 (1) 1702403; 10.1183/13993003.02403-2017 Year: 2018 Pulmonary arterial hypertension: treatment options Source: International Congress 2018 – ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED Year: 2018 Microvascular disease in chronic thromboembolic pulmonary hypertension: the story continues Source: Eur Respir J 2014; 44: 1121-1122 Year: 2014 The revolution of pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 361-363 Year: 2016 Parasympathetic activity in pulmonary arterial hypertension: could a simple measure do the trick? Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise Year: 2018 Systemic consequences of pulmonary arterial hypertension Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases Year: 2019 Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer? Source: Eur Respir J 2009; 33: 1247-1249 Year: 2009 When is pulmonary hypertension not pulmonary hypertension? Source: Eur Respir J 2001; 18: Suppl. 33, 522s Year: 2001